# The role of DOT1L methyltransferase in controlling the noncoding transcriptome

> **NIH NIH R01** · BOSTON UNIVERSITY MEDICAL CAMPUS · 2022 · $25,499

## Abstract

The broad goal of our research is to understand how gene expression is regulated during animal development.
Our specific interest is in finding natural regulators of endogenous double-stranded RNA production and nuclear
RNA interference. In this regard, we are focusing on the relationship between RNA interference and the histone
H3 lysine 79 DOT1L methyltransferase complex. A connection between the DOT1L interacting partner ZFP-1
(AF10 in mammals) and RNAi in C. elegans was suggested by genetic experiments 13-15 years ago. To
understand this connection, my laboratory undertook molecular and genomic studies of ZFP-1 and DOT1L.
These studies not only confirmed the connection to RNAi, but also provided novel insights about the conserved
role of DOT1L in transcription regulation. The DOT1L enzyme is essential for mammalian development and has
been implicated in the pathogenesis of leukemia and breast cancer. However, the exact role of DOT1L in gene
regulation is not clear. Preliminary work from our lab has begun to reveal this role; we have discovered that
DOT1L and H3K79 methylation globally suppress non-coding RNA transcription in C. elegans, including that of
antisense and enhancer RNAs. Our preliminary data strongly suggest ectopic dsRNA formation and small RNA
production upon DOT1L loss-of-function. Our main goals are: 1) to detect and characterize these dsRNA and
small RNA molecules in C. elegans; 2) to explore the possibility that the dsRNA suppressing function of DOT1L
is conserved in mammals, and 3) to investigate the mechanism of transcription regulation by DOT1L in
development using the C. elegans and zebrafish systems.

## Key facts

- **NIH application ID:** 10581918
- **Project number:** 3R01GM135199-02S1
- **Recipient organization:** BOSTON UNIVERSITY MEDICAL CAMPUS
- **Principal Investigator:** Alla Grishok
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $25,499
- **Award type:** 3
- **Project period:** 2020-08-01 → 2024-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10581918

## Citation

> US National Institutes of Health, RePORTER application 10581918, The role of DOT1L methyltransferase in controlling the noncoding transcriptome (3R01GM135199-02S1). Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/grant/nih/10581918. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*